Merck & Co., Inc. (MRK)
USD 98.34
(-1.72%)
USD 98.34
(-1.72%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 365 Million USD | -97.49% |
| 2022 | 14.51 Billion USD | 11.27% |
| 2021 | 13.04 Billion USD | 84.65% |
| 2020 | 7.06 Billion USD | -28.2% |
| 2019 | 9.84 Billion USD | 58.25% |
| 2018 | 6.22 Billion USD | 142.21% |
| 2017 | 2.56 Billion USD | -54.88% |
| 2016 | 5.69 Billion USD | 28.12% |
| 2015 | 4.44 Billion USD | -62.73% |
| 2014 | 11.92 Billion USD | 170.66% |
| 2013 | 4.4 Billion USD | -33.88% |
| 2012 | 6.66 Billion USD | 6.2% |
| 2011 | 6.27 Billion USD | 628.46% |
| 2010 | 861 Million USD | -93.33% |
| 2009 | 12.9 Billion USD | 65.22% |
| 2008 | 7.8 Billion USD | 138.4% |
| 2007 | 3.27 Billion USD | -26.13% |
| 2006 | 4.43 Billion USD | -4.26% |
| 2005 | 4.63 Billion USD | -20.33% |
| 2004 | 5.81 Billion USD | -14.9% |
| 2003 | 6.83 Billion USD | -4.46% |
| 2002 | 7.14 Billion USD | -1.82% |
| 2001 | 7.28 Billion USD | 6.74% |
| 2000 | 6.82 Billion USD | 15.81% |
| 1999 | 5.89 Billion USD | 12.24% |
| 1998 | 5.24 Billion USD | 13.74% |
| 1997 | 4.61 Billion USD | 18.88% |
| 1996 | 3.88 Billion USD | 16.37% |
| 1995 | 3.33 Billion USD | 11.28% |
| 1994 | 2.99 Billion USD | 38.35% |
| 1993 | 2.16 Billion USD | 9.17% |
| 1992 | 1.98 Billion USD | -6.48% |
| 1991 | 2.12 Billion USD | 19.12% |
| 1990 | 1.78 Billion USD | 19.11% |
| 1989 | 1.49 Billion USD | 23.91% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 3.15 Billion USD | -42.13% |
| 2024 Q1 | 4.76 Billion USD | 488.42% |
| 2024 Q2 | 5.45 Billion USD | 14.55% |
| 2023 Q4 | -1.22 Billion USD | -125.84% |
| 2023 Q2 | -5.97 Billion USD | -311.8% |
| 2023 Q1 | 2.82 Billion USD | -6.5% |
| 2023 Q3 | 4.74 Billion USD | 179.41% |
| 2023 FY | 365 Million USD | -97.49% |
| 2022 Q4 | 3.01 Billion USD | -7.11% |
| 2022 FY | 14.51 Billion USD | 11.27% |
| 2022 Q2 | 3.94 Billion USD | -8.49% |
| 2022 Q3 | 3.24 Billion USD | -17.65% |
| 2022 Q1 | 4.31 Billion USD | 14.69% |
| 2021 FY | 13.04 Billion USD | 84.65% |
| 2021 Q1 | 3.17 Billion USD | 251.81% |
| 2021 Q2 | 1.54 Billion USD | -51.4% |
| 2021 Q3 | 4.56 Billion USD | 195.6% |
| 2021 Q4 | 3.75 Billion USD | -17.71% |
| 2020 Q2 | 3 Billion USD | -6.74% |
| 2020 FY | 7.06 Billion USD | -28.2% |
| 2020 Q1 | 3.21 Billion USD | 36.63% |
| 2020 Q3 | 2.94 Billion USD | -2.03% |
| 2020 Q4 | -2.09 Billion USD | -171.2% |
| 2019 Q1 | 2.91 Billion USD | 59.55% |
| 2019 Q2 | 2.67 Billion USD | -8.4% |
| 2019 Q3 | 1.9 Billion USD | -28.8% |
| 2019 FY | 9.84 Billion USD | 58.25% |
| 2019 Q4 | 2.35 Billion USD | 23.93% |
| 2018 Q2 | 1.7 Billion USD | 131.93% |
| 2018 FY | 6.22 Billion USD | 142.21% |
| 2018 Q1 | 736 Million USD | 184.4% |
| 2018 Q3 | 1.95 Billion USD | 14.24% |
| 2018 Q4 | 1.82 Billion USD | -6.31% |
| 2017 Q4 | -872 Million USD | -1457.14% |
| 2017 FY | 2.56 Billion USD | -54.88% |
| 2017 Q1 | 1.55 Billion USD | 31.78% |
| 2017 Q2 | 1.94 Billion USD | 25.47% |
| 2017 Q3 | -56 Million USD | -102.88% |
| 2016 Q3 | 2.18 Billion USD | 81.24% |
| 2016 FY | 5.69 Billion USD | 28.12% |
| 2016 Q2 | 1.2 Billion USD | 7.11% |
| 2016 Q4 | 1.17 Billion USD | -46.11% |
| 2016 Q1 | 1.12 Billion USD | 15.15% |
| 2015 Q4 | 977 Million USD | -46.5% |
| 2015 Q2 | 687 Million USD | -27.91% |
| 2015 Q1 | 953 Million USD | -86.97% |
| 2015 FY | 4.44 Billion USD | -62.73% |
| 2015 Q3 | 1.82 Billion USD | 165.79% |
| 2014 FY | 11.92 Billion USD | 170.66% |
| 2014 Q3 | 895 Million USD | -55.34% |
| 2014 Q2 | 2 Billion USD | 17.54% |
| 2014 Q1 | 1.7 Billion USD | 118.31% |
| 2014 Q4 | 7.31 Billion USD | 717.43% |
| 2013 FY | 4.4 Billion USD | -33.88% |
| 2013 Q1 | 1.59 Billion USD | 13.7% |
| 2013 Q4 | 781 Million USD | -30.52% |
| 2013 Q3 | 1.12 Billion USD | 24.06% |
| 2013 Q2 | 906 Million USD | -43.13% |
| 2012 Q3 | 1.72 Billion USD | -3.52% |
| 2012 Q4 | 1.4 Billion USD | -18.97% |
| 2012 FY | 6.66 Billion USD | 6.2% |
| 2012 Q1 | 1.73 Billion USD | 14.81% |
| 2012 Q2 | 1.79 Billion USD | 3.23% |
| 2011 Q1 | 1.04 Billion USD | 296.16% |
| 2011 Q4 | 1.51 Billion USD | -10.64% |
| 2011 Q2 | 2.02 Billion USD | 94.06% |
| 2011 Q3 | 1.69 Billion USD | -16.4% |
| 2011 FY | 6.27 Billion USD | 628.46% |
| 2010 Q2 | 752 Million USD | 151.51% |
| 2010 Q3 | 342 Million USD | -54.52% |
| 2010 Q4 | -531.7 Million USD | -255.47% |
| 2010 FY | 861 Million USD | -93.33% |
| 2010 Q1 | 299 Million USD | -95.4% |
| 2009 Q3 | 3.42 Billion USD | 120.03% |
| 2009 Q4 | 6.49 Billion USD | 89.69% |
| 2009 Q2 | 1.55 Billion USD | 9.21% |
| 2009 Q1 | 1.42 Billion USD | -13.36% |
| 2009 FY | 12.9 Billion USD | 65.22% |
| 2008 Q4 | 1.64 Billion USD | 50.53% |
| 2008 FY | 7.8 Billion USD | 138.4% |
| 2008 Q3 | 1.09 Billion USD | -38.21% |
| 2008 Q1 | 3.3 Billion USD | 302.5% |
| 2008 Q2 | 1.76 Billion USD | -46.46% |
| 2007 Q3 | 1.52 Billion USD | -9.0% |
| 2007 FY | 3.27 Billion USD | -26.13% |
| 2007 Q1 | 1.7 Billion USD | 259.63% |
| 2007 Q2 | 1.67 Billion USD | -1.64% |
| 2007 Q4 | -1.63 Billion USD | -206.91% |
| 2006 Q4 | 473.9 Million USD | -49.62% |
| 2006 FY | 4.43 Billion USD | -4.26% |
| 2006 Q3 | 940.6 Million USD | -37.26% |
| 2006 Q2 | 1.49 Billion USD | -1.36% |
| 2006 Q1 | 1.52 Billion USD | 35.75% |
| 2005 Q3 | 1.42 Billion USD | 97.18% |
| 2005 Q2 | 720.6 Million USD | -47.41% |
| 2005 Q1 | 1.37 Billion USD | 24.43% |
| 2005 FY | 4.63 Billion USD | -20.33% |
| 2005 Q4 | 1.11 Billion USD | -21.2% |
| 2004 Q4 | 1.1 Billion USD | -16.94% |
| 2004 Q3 | 1.32 Billion USD | -25.03% |
| 2004 Q2 | 1.76 Billion USD | 9.24% |
| 2004 Q1 | 1.61 Billion USD | 16.01% |
| 2004 FY | 5.81 Billion USD | -14.9% |
| 2003 Q4 | 1.39 Billion USD | -24.92% |
| 2003 FY | 6.83 Billion USD | -4.46% |
| 2003 Q2 | 1.86 Billion USD | 9.16% |
| 2003 Q3 | 1.85 Billion USD | -0.47% |
| 2003 Q1 | 1.71 Billion USD | -9.49% |
| 2002 Q3 | 1.88 Billion USD | 7.61% |
| 2002 FY | 7.14 Billion USD | -1.82% |
| 2002 Q4 | 1.88 Billion USD | 0.31% |
| 2002 Q2 | 1.75 Billion USD | 7.74% |
| 2002 Q1 | 1.62 Billion USD | -12.68% |
| 2001 Q3 | 1.94 Billion USD | 7.32% |
| 2001 Q4 | 1.86 Billion USD | -4.48% |
| 2001 FY | 7.28 Billion USD | 6.74% |
| 2001 Q1 | 1.65 Billion USD | -6.07% |
| 2001 Q2 | 1.81 Billion USD | 9.54% |
| 2000 Q3 | 1.83 Billion USD | 6.63% |
| 2000 Q2 | 1.72 Billion USD | 14.81% |
| 2000 Q1 | 1.49 Billion USD | -4.68% |
| 2000 Q4 | 1.76 Billion USD | -3.89% |
| 2000 FY | 6.82 Billion USD | 15.81% |
| 1999 Q3 | 1.53 Billion USD | 4.16% |
| 1999 Q2 | 1.47 Billion USD | 13.73% |
| 1999 FY | 5.89 Billion USD | 12.24% |
| 1999 Q4 | 1.57 Billion USD | 2.18% |
| 1999 Q1 | 1.29 Billion USD | -7.22% |
| 1998 Q4 | 1.4 Billion USD | 2.47% |
| 1998 Q2 | 1.31 Billion USD | 13.03% |
| 1998 FY | 5.24 Billion USD | 13.74% |
| 1998 Q3 | 1.36 Billion USD | 3.87% |
| 1998 Q1 | 1.16 Billion USD | -6.26% |
| 1997 Q2 | 1.15 Billion USD | 13.14% |
| 1997 FY | 4.61 Billion USD | 18.88% |
| 1997 Q3 | 1.19 Billion USD | 3.71% |
| 1997 Q4 | 1.24 Billion USD | 3.76% |
| 1997 Q1 | 1.02 Billion USD | -2.22% |
| 1996 FY | 3.88 Billion USD | 16.37% |
| 1996 Q2 | 972.1 Million USD | 12.54% |
| 1996 Q3 | 1 Billion USD | 3.07% |
| 1996 Q4 | 1.04 Billion USD | 4.15% |
| 1996 Q1 | 863.8 Million USD | 0.7% |
| 1995 Q1 | 757.4 Million USD | -2.01% |
| 1995 Q3 | 861.9 Million USD | 0.44% |
| 1995 FY | 3.33 Billion USD | 11.28% |
| 1995 Q4 | 857.8 Million USD | -0.48% |
| 1995 Q2 | 858.1 Million USD | 13.3% |
| 1994 Q4 | 772.9 Million USD | -1.52% |
| 1994 FY | 2.99 Billion USD | 38.35% |
| 1994 Q1 | 675.2 Million USD | 0.15% |
| 1994 Q2 | 764.1 Million USD | 13.17% |
| 1994 Q3 | 784.8 Million USD | 2.71% |
| 1993 Q1 | 613.8 Million USD | 421.94% |
| 1993 Q2 | 172.6 Million USD | -71.88% |
| 1993 FY | 2.16 Billion USD | 9.17% |
| 1993 Q4 | 674.2 Million USD | -4.46% |
| 1993 Q3 | 705.7 Million USD | 308.86% |
| 1992 Q1 | 568.7 Million USD | 7.34% |
| 1992 Q2 | 653.4 Million USD | 14.89% |
| 1992 FY | 1.98 Billion USD | -6.48% |
| 1992 Q3 | 644.5 Million USD | -1.36% |
| 1992 Q4 | 117.6 Million USD | -81.75% |
| 1991 Q4 | 529.8 Million USD | -4.09% |
| 1991 FY | 2.12 Billion USD | 19.12% |
| 1991 Q3 | 552.4 Million USD | -0.65% |
| 1991 Q2 | 556 Million USD | 14.99% |
| 1991 Q1 | 483.5 Million USD | 9.34% |
| 1990 FY | 1.78 Billion USD | 19.11% |
| 1990 Q4 | 442.2 Million USD | -4.9% |
| 1990 Q3 | 465 Million USD | -1.11% |
| 1990 Q2 | 470.2 Million USD | 16.44% |
| 1990 Q1 | 403.8 Million USD | 9.76% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q4 | 367.9 Million USD | -5.79% |
| 1989 Q3 | 390.5 Million USD | 0.0% |
| 1989 FY | 1.49 Billion USD | 23.91% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbbVie Inc. | 4.86 Billion USD | 92.494% |
| Bristol-Myers Squibb Company | 8.02 Billion USD | 95.452% |
| Bristol-Myers Squibb Company Ce | 8.02 Billion USD | 95.452% |
| Johnson & Johnson | 35.15 Billion USD | 98.962% |
| Eli Lilly and Company | 5.24 Billion USD | 93.035% |
| Novartis AG | 14.85 Billion USD | 97.542% |
| Organon & Co. | 1.02 Billion USD | 64.321% |
| Pfizer Inc. | 2.11 Billion USD | 82.775% |